effect overlay
activetrials
Stroke
Stroke
TENACITY

A Phase III, prospective, randomized, open-label, blinded endpoint assessment (PROBE) to assess efficacy and safety of IV tenecteplase vs standard of care in patients with acute ischemic stroke (including wake-up stroke), last known well >4.5 h with imaging evidence of salvageable ischemic tissue

HREC: 2025.290
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Commercial
Stroke
Stroke
SELECT LATE

Medical Management with Endovascular Thrombectomy versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

HREC: 2025.219
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Non-Commercial
Stroke
Stroke
EAST-STROKE

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE

HREC: 2024.344
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Non-Commercial
Stroke
Stroke
ICU patients following endovascular thrombectomy

Evaluation of patients admitted to ICU following endovascular thrombectomy for acute ischaemic stroke

HREC: 2025.216
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Dr Chloe Mutimer
Funding: Non-Commercial
Stroke
Stroke
International Registry for Iatrogenic CAA

International Registry for Iatrogenic Cerebral Amyloid Angiopathy (CAA)

HREC: 2025.159
Principal Investigator: Dr Chloe Mutimer
Coordinator contact:
Funding: Non-Commercial